(Q42465607)

English

The farnesyl transferase inhibitor R115777 (Zarnestra) synergistically enhances growth inhibition and apoptosis induced on epidermoid cancer cells by Zoledronic acid (Zometa) and Pamidronate

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

The farnesyl transferase inhibitor R115777 (Zarnestra) synergistically enhances growth inhibition and apoptosis induced on epidermoid cancer cells by Zoledronic acid (Zometa) and Pamidronate (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

zoledronic acid

1 reference

based on heuristic

inferred from title

Michele Caraglia

1

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Alfredo Budillon

11

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Annamaria Colao

7

object named as

Annamaria Colao

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Pierfrancesco Tassone

10

object named as

Pierfrancesco Tassone

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Pierosandro Tagliaferri

9

object named as

Pierosandro Tagliaferri

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

author name string

Anna Maria D'Alessandro

2

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Monica Marra

3

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Gaia Giuberti

4

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Giovanni Vitale

5

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Caterina Viscomi

6

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Salvatore Del Prete

8

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Salvatore Venuta

12

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Alberto Abbruzzese

13

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

language of work or name

0 references

publication date

1 September 2004

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

41

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

6900-6913

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

21 January 2018

Safety and efficacy of bisphosphonates beyond 24 months in cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

21 January 2018

Hypoxia induces the activation of the phosphatidylinositol 3-kinase/Akt cell survival pathway in PC12 cells: protective role in apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

21 January 2018

In vitro cytoreductive effects on multiple myeloma cells induced by bisphosphonates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

21 January 2018

New bisphosphonates in the treatment of bone metastases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

21 January 2018

Rho signals to cell growth and apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

21 January 2018

Different doses of pamidronate in patients with painful osteolytic bone metastases.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

21 January 2018

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

21 January 2018

Treatment of bone metastases from breast cancer with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

21 January 2018

Dual protein farnesyltransferase-geranylgeranyltransferase-I inhibitors as potential cancer chemotherapeutic agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

21 January 2018

Farnesyl protein transferase inhibitors and other therapies targeting the Ras signal transduction pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

21 January 2018

High affinity for farnesyltransferase and alternative prenylation contribute individually to K-Ras4B resistance to farnesyltransferase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

21 January 2018

Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

21 January 2018

Organization and regulation of mitogen-activated protein kinase signaling pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

21 January 2018

Farnesyl transferase inhibitors as anticancer agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

21 January 2018

All ras proteins are polyisoprenylated but only some are palmitoylated

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

21 January 2018

Farnesyl transferase inhibitors: a novel targeted tnerapy for cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

21 January 2018

The involvement of PI 3-K/Akt-dependent up-regulation of Mcl-1 in the prevention of apoptosis of Hep3B cells by interleukin-6.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

21 January 2018

Non-Ras targets of farnesyltransferase inhibitors: focus on Rho.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

21 January 2018

Fibroblast growth factor and insulin-like growth factor differentially modulate the apoptosis and G1 arrest induced by anti-epidermal growth factor receptor monoclonal antibody.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

21 January 2018

Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

21 January 2018

Sclerosis of lytic bone metastases after disodium aminohydroxypropylidene bisphosphonate (APD) in patients with breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

21 January 2018

Epidermal growth factor protects neuronal cells in vivo and in vitro against transient forebrain ischemia- and free radical-induced injuries

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

21 January 2018

Tyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

21 January 2018

Protein prenylation: genes, enzymes, targets, and functions.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

21 January 2018

Farnesyltransferase and geranylgeranyltransferase I inhibitors in cancer therapy: important mechanistic and bench to bedside issues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

21 January 2018

Bisphosphonates induce apoptosis in human breast cancer cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

21 January 2018

Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

21 January 2018

The EGF receptor provides an essential survival signal for SOS-dependent skin tumor development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

21 January 2018

Farnesyl thiosalicylic acid inhibits the growth of melanoma cells through a combination of cytostatic and pro-apoptotic effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

21 January 2018

Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

21 January 2018

Nitrogen-containing bisphosphonates inhibit isopentenyl pyrophosphate isomerase/farnesyl pyrophosphate synthase activity with relative potencies corresponding to their antiresorptive potencies in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

21 January 2018

Farnesyl pyrophosphate synthase is the molecular target of nitrogen-containing bisphosphonates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

21 January 2018

Pamidronate improves the quality of life and induces clinical remission of bone metastases in patients with thyroid cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

21 January 2018

Apoptosis suppression by Raf-1 and MEK1 requires MEK- and phosphatidylinositol 3-kinase-dependent signals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

21 January 2018

Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

21 January 2018

Akt regulates cell survival and apoptosis at a postmitochondrial level

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

21 January 2018

Computerized quantitation of synergism and antagonism of taxol, topotecan, and cisplatin against human teratocarcinoma cell growth: a rational approach to clinical protocol design

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

7 January 2021

based on heuristic

inferred from DOI database lookup

The Ras-Raf-MEK-ERK pathway in the treatment of cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

7 January 2021

based on heuristic

inferred from DOI database lookup

Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

7 January 2021

based on heuristic

inferred from DOI database lookup

Farnesyltransferase inhibitors alter the prenylation and growth-stimulating function of RhoB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

7 January 2021

based on heuristic

inferred from DOI database lookup

Bisphosphonates induce apoptosis in mouse macrophage-like cells in vitro by a nitric oxide-independent mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

7 January 2021

based on heuristic

inferred from DOI database lookup

Involvement of nitric oxide in farnesyltransferase inhibitor-mediated apoptosis in chronic myeloid leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

7 January 2021

based on heuristic

inferred from DOI database lookup

EGF receptor signaling inhibits keratinocyte apoptosis: evidence for mediation by Bcl-XL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

7 January 2021

based on heuristic

inferred from DOI database lookup

Growth inhibition and synergistic induction of apoptosis by zoledronate and dexamethasone in human myeloma cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of nitrogen-containing bisphosphonates on human epithelial (Caco-2) cells, an in vitro model for intestinal epithelium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of PC12 cell death by N-acetylcysteine requires activation of the Ras pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207814

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.ONC.1207814

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42465607&oldid=2205414930"